Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice

Clinical Microbiology and Infection

Volumn 12, Issue 11, 2006, Pages 1105-1111

  Buijs, J ^a,b   Dofferhoff, A S M ^a   Mouton, J W ^a   van der Meer, J W M ^c  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^b Zuyderland Medical Centre   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Endotoxin; Escherichia coli; Filaments; Mouse model; Pathophysiological effects; Spheroplasts

Indexed keywords

CEFTAZIDIME; CYTOKINE; ENDOTOXIN; INTERLEUKIN 6; MEROPENEM; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BACTERIAL INFECTION; BACTERIAL TRANSLOCATION; BACTERIUM TRANSFORMATION; CELL SHAPE; COLONY FORMING UNIT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG EXPOSURE; DRUG WITHDRAWAL; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MORTALITY; MOUSE; NEUTROPENIA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPHEROPLAST; SURVIVAL; THIGH; TOXIN SYNTHESIS;

BACILLI (CLASS); BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MURINAE;

EID: 33749050972     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01503.x     Document Type: Article

References (41)

1. Maury E, Barakett V, Blanchard H et al. Circulating endotoxin during initial antibiotic treatment for severe gram-negative bacteremic infections. J Infect Dis 1998; 178: 270-273.
2. Heinemann M. Sepsis und antibiotika-induzierte Freisetzung von Endotoxinen. Konsequenzen fuer die Therapie? Chemother J 1999; 8: 176-182.
3. Lei MG, Gao JJ, Morrison DC et al. Pathogenesis of sepsis: Current concepts and emerging therapies. Mod Med 2003; 100: 524-529.
4. Morrison DC, Ryan J. Endotoxin and disease mechanisms. Ann Rev Med 1987; 38: 417-432.
5. Van Deventer SJ, Buller HR, Ten Cate JW, Sturk A, Pauw W. Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet 1988; 316: 605-608.
6. Hopkin BD. Frapper fort ou doucement: A gram-negative dilemma. Lancet 1978; ii: 1193-1194.
7. Rietschel E, Brade H. Bacterial endotoxins. Sci Am 1992; 267: 54-61.
8. Leeson MC, Fujihara Y, Morrison DC. Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria. Infect Immun 1994; 62: 4975-4980.
9. Prins JM, Van Deventer SJ, Kuijper EJ, Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 1994; 38: 1211-1218.
10. Periti P, Mazzei T. Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: A review. J Chemother 1998; 10: 427-448.
11. Norimatsu M, Morrison DC. Correlation of antibiotic-induced endotoxin release and cytokine production in E. coli inoculated mouse whole blood ex-vivo. J Infect Dis 1998; 177: 1302-1307.
12. Cross AS, Sadoff JC, Bernton KE, Gemski P. Pretreatment with recombinant murine tumor necrosis factor-α/cachectin and murine interleukin 1-α protects mice from lethal bacterial infection. J Exp Med 1989; 169: 2021-2027.
13. Roll JT, Young KM, Czuprynski CJ. Human rTNF-alpha augments anti-bacterial resistance in mice: Potentiation of its effects by recombinant human rIL-1-alpha. Immunology 1990; 69: 316-322.
14. Havell EA. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol 1989; 143: 2894-2899.
15. Young LS. Endotoxins and mediators, an introduction. Prog Clin Biol Res 1991; 367: 1-7.
16. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; i: 355-357.
17. Gardlund B, Siolin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: Correlation with disease severity. J Infect Dis 1995; 172: 296-301.
18. Netea MG, Van der Meer JW, van Deuren M, Kullberg BJ. Proinflammatory cytokines and sepsis syndrome: Not enough or too much of a good thing? Trends Immunol 2003; 24: 254-258.
19. Shenep JL, Barton RP, Morgan KA. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis 1985; 151: 1012-1018.
20. Jackson JJ, Kropp H. Differences in mode of action of beta-lactam antibiotics, influence on morphology, LPS release and in-vivo antibiotic efficacy. J Endotox Res 1996; 3: 201-218.
21. Eng RM, Smith SM, Fan-Havard P, Ogbara T. Effect of antibiotics on endotoxin release from Gram-negative bacteria. Diagn Microbiol Infect Dis 1993; 16: 185-189.
22. Prins JM. Endotoxin, antibiotics and inflammation in Gram-negative infections. In: Brade H, Opal S, Vogel S, Morrison D, eds, Endotoxin in health and disease. New York: Dekker, 1999; 887-897.
23. Nanninga N. Morphogenesis of Escherichia coli. Microbiol Mol Biol Rev 1998; 62: 110-129.
24. Dofferhoff AS, Buijs J. The influence of antibiotic-induced filament formation on the release of endotoxin from Gram-negative bacteria. J Endotox Res 1996; 3: 187-194.
25. Gould IM, MacKenzie FM. The response of Enterobacteriaceae to beta-lactam antibiotics-'round forms, filaments and the root of all evil'. J Antimicrob Chemother 1997; 40: 495-499.
26. Horii T, Kobayashi M, Sato K, Ichiyama S, Ohta M. An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of Gram-negative bacilli. J Antimicrob Chemother 1998; 41: 435-442.
27. Kunst MW, Mattie H. Cefazolin and cephradine: Relationship between serum concentrations and tissue contents in mice. Infection 1978; 6: 166-170.
28. Mattie H, Van Dojjum AM, Brus-Weijer L, Krul AM, van Strijen E. Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics. J Infect Dis 1990; 162: 717-722.
29. Andes D, Craig WA. Animal model pharmacokinetics and pharmacodynamics: A critical review. Int J Antimicrob Agents 2002; 19: 261-268.
30. Simon DM, Koeing G, Trenholme G. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J Infect Dis 1991; 164: 800-802.
31. Huang MB, Baker CN, Banerjee S, Tenover FC. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J Clin Microbiol 1992; 30: 3243-3248.
32. Barry AL, Brown SD, Fuchs PC. In vitro activity of ceftizoxime, cefuroxime, ceftriaxone, cefotaxime and penicillin against Streptococcus pneumoniae as determined by three quantitative methods. Eur J Clin Microbiol Infect Dis 1996; 15: 344-346.
33. Jackson JJ, Kropp H. Beta-lactam antibiotic-induced release of free endotoxin: In vitro comparison of penicillin-binding protein (PBP)2-specific imipenem and PBP-3-specific ceftazidime. J Infect Dis 1992; 165: 1033-1041.
34. Chen K, Sun GW, Chua KL, Gan YH. Modified virulence of antibiotic-induced Burkholderia pseudomallei filaments. Antimicrob Agents Chemother 2005; 49: 1002-1009.
35. Dofferhoff AS, Potthoff H, Bom VJ. The release of endotoxin, TNF and IL-6 during the antibiotic treatment of experimental gram-negative sepsis. J Endotox Res 1995; 2: 37-44.
36. Cannon JG, Tompkins RG, Gelfland JA et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990; 161: 79-84.
37. Dofferhoff AS, Bom VJ, de Vries-Hospers HG et al. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute phase proteins during the treatment of severe sepsis in humans. Crit Care Med 1992; 20: 185-192.
38. Friedland IR, Jafari H, Ehrett S et al. Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. J Infect Dis 1993; 168: 657-662.
39. Horn DL, Opal S, Lomastro E. Antibiotics, cytokines and endotoxin: A complex and evolving relationship in gram-negative sepsis. Scand J Infect Dis 1996; 101 (suppl): 9-13.
40. Horn DL, Morrison DC, Opal SM, Silverstein R, Visvanathan K, Zabriskie JB. What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium. Clin Infect Dis 2000; 31: 851-858.
41. Dofferhoff AS, Nijland JH, de Vries-Hospers HG, Mulder P, Weits J, Bom VJ. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: An in-vitro and in-vivo study. Scand J Infect Dis 1991; 23: 745-754.